32 studies found for:    Open Studies | "Anus Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anus Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy
2 Recruiting International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
Condition: Squamous Cell Carcinoma of the Anus
Interventions: Drug: Cisplatin;   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin;   Drug: Paclitaxel
3 Not yet recruiting Functional Outcomes Following Anal Cancer Treatment
Condition: Anal Cancer
Intervention:
4 Recruiting A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Intervention: Biological: Advaxis
5 Recruiting Molecular Genetic and Pathological Studies of Anal Tumors
Conditions: Rectal Cancer;   Colon Cancer;   Colonic Neoplasms;   Anal Cancer
Intervention: Other: genetic analysis
6 Recruiting Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Intervention:
7 Unknown  Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Condition: Anal Cancer
Intervention: Other: FMISO-PET, FDG-PET-CT and Magnetic Resonance Imaging (MRI)
8 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
9 Recruiting Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
Condition: Anal Cancer
Interventions: Drug: Tempol;   Drug: 5-Fluorouracil;   Drug: Mitomycin-C;   Procedure: Radiation Therapy
10 Unknown  Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Conditions: Anal Cancer;   Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Fallopian Tube Cancer;   Gastrointestinal Complications;   Ovarian Cancer;   Radiation Toxicity;   Sarcoma
Interventions: Dietary Supplement: dietary intervention;   Other: laboratory biomarker analysis;   Procedure: gastrointestinal complications management/prevention;   Procedure: management of therapy complications;   Radiation: selective external radiation therapy
11 Recruiting Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
Conditions: Anal Cancer;   Neoplasm of Uncertain Malignant Potential;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Other: clinical observation;   Procedure: infrared photocoagulation therapy
12 Recruiting Alkagin Paste in the Prevention of Radiation Dermatitis
Conditions: Anus Neoplasms;   Rectal Neoplasms;   Urogenital Neoplasms
Interventions: Other: Aveeno cream;   Other: Alkagin paste
13 Recruiting [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Conditions: Uterine Cervical Neoplasms;   Endometrial Neoplasms;   Anus Neoplasms;   Rectal Neoplasms;   Prostatic Neoplasms
Intervention: Radiation: Bone marrow sparing IMRT radiation therapy
14 Recruiting Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
Conditions: Anal Cancer;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Procedure: comparison of screening methods;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: quality-of-life assessment
15 Recruiting Chemoradiation-Induced Nausea and Emesis: Quality of Life
Conditions: Gastric Cancer;   Pancreatic Cancer;   Cervical Cancer;   Vulvar Cancer;   Endometrial Cancer;   Anal Cancer
Interventions: Behavioral: Interview;   Other: Questionnaire
16 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
17 Recruiting Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients
Conditions: Anal AIN3;   Anal Carcinoma
Intervention:
18 Recruiting Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0
Condition: Locally Advanced Cancer in the Anal Region.
Interventions: Drug: Cetuximab;   Drug: Mitomycin C;   Drug: 5-Fluoruracil;   Radiation: Radiotherapy
19 Recruiting A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fluderabine;   Drug: Cycolphosphamide;   Biological: Young TIL;   Biological: Aldesleukin
20 Recruiting Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer;   Gastrointestinal Neoplasms;   Colon Rectal Cancer Adenocarcinoma;   Esophageal Cancer;   Gall Bladder Cancer;   Gastric (Stomach) Cancer;   Gastrooesophageal Cancer;   Gastrointestinal Stromal Tumor (GIST);   Hepatobiliary Neoplasm;   Liver Carcinoma;   Gallbladder Carcinoma;   Bile Duct Carcinoma;   Carcinoma of the Large Intestine;   Anal Cancer
Intervention: Procedure: Observation

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years